Confirming what a growing number of studies has shown, the U.S. Preventive Services Task Force (USPSTF), a government panel that periodically reviews the evidence on screening and other preventive treatments, recommended this week that postmenopausal women should not take hormone replacement therapy to prevent conditions such as heart disease, cancer or dementia.